Gestational Diabetes clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Conscious Pregnancy: Supporting Maternal Cardiometabolic Health With Mindfulness
open to eligible females ages 18 years and up
A pilot randomized control trial (RCT) to examine the efficacy of a culturally tailored mindfulness intervention upon fasting cardiometabolic factors (including markers of glycemic control) and inflammatory gene expression in n=60 (n=30 intervention, n=30 wait-list control) low-income Spanish-speaking Latina pregnant women. The study will be conducted in partnership with MOMS, a nonprofit community organization that serves low-income pregnant and postpartum women.
Santa Ana 5392900, California 5332921
Continuation of the nuMoM2b Heart Health Study
Sorry, accepting new patients by invitation only
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in U.S. women at all ages, and large knowledge gaps exist in CVD predictive and preventative strategies for women. The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively collected for up to 7 years thereafter. The overarching scientific goal of this study is to define the relationship between adverse pregnancy outcomes (APOs) and CVD to optimize CVD prediction, prevention, and treatment strategies for women. Continued follow-up of this observational cohort, building on a foundation of existing high-quality data, biospecimens, and administrative structures with a robust framework for ancillary study development and implementation, provides a unique opportunity to address knowledge gaps regarding the early mechanisms and trajectory of CVD in women.
Orange 5379513, California 5332921 and other locations
Our lead scientists for Gestational Diabetes research studies include Karen L Lindsay, RD, PhD Lauren E Gyllenhammer, PhD.
Last updated: